What would be the NPO (nothing by mouth) dose of Lantus (insulin glargine) for a 65-year-old male with type 2 diabetes taking 15 units daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPO Dose of Lantus for a 65-Year-Old Male with Type 2 Diabetes

Continue the full 15 units of Lantus (insulin glargine) daily when NPO, as basal insulin provides essential background insulin coverage independent of nutritional intake. 1

Rationale for Continuing Full Basal Dose

  • Basal insulin like Lantus provides continuous background insulin coverage that is required 24 hours daily regardless of eating status, mimicking the body's baseline insulin secretion that occurs even during fasting states 1, 2

  • The 2017 Diabetes Care guidelines for hospitalized older adults explicitly state that when patients have reduced oral intake or become NPO, the basal insulin should be maintained while adding dextrose infusion (10% dextrose) to prevent hypoglycemia rather than reducing the basal dose 1

  • Lantus has a peakless 24-hour action profile, meaning it does not have significant peaks that would cause hypoglycemia during NPO periods when administered at appropriate doses 2, 3

Critical Management During NPO Status

  • Start 10% dextrose infusion (typically 75-100 mL/hour) when the patient becomes NPO to provide glucose substrate while maintaining basal insulin coverage 1

  • Monitor blood glucose every 4-6 hours during NPO status, with more frequent checks if any value falls below 100 mg/dL 1

  • Hold all prandial (mealtime) insulin completely during NPO periods, as these are specifically designed to cover carbohydrate intake 1

Dose Adjustment Considerations

  • If blood glucose drops below 70 mg/dL during NPO status despite dextrose infusion, reduce the Lantus dose by 10-20% (to 12-13.5 units) 1

  • For older adults (age 65) with any degree of renal impairment, frailty, or recurrent hypoglycemia, consider reducing to 80% of the usual dose (12 units) prophylactically when NPO 1

  • The 15-unit daily dose is already conservative for a 65-year-old, suggesting either good glycemic control or intentional conservative dosing, which supports maintaining the full dose during brief NPO periods 1

Common Pitfalls to Avoid

  • Never discontinue basal insulin entirely when NPO—this is the most common error and leads to diabetic ketoacidosis in type 1 diabetes and severe hyperglycemia in type 2 diabetes 1

  • Do not use sliding scale regular insulin alone during NPO periods without basal insulin coverage, as this approach results in poor glycemic control and higher complication rates 1

  • Failing to provide dextrose infusion when holding oral intake while continuing basal insulin is the second most common error, leading to hypoglycemia 1

  • For procedures or imaging requiring NPO status, coordinate timing so the patient receives Lantus at the usual time (whether morning or evening dosing) to maintain steady-state levels 1

Special Circumstances Requiring Dose Reduction

  • Reduce to 50-80% of usual dose (7.5-12 units) if the patient has: 1

    • Acute kidney injury or chronic kidney disease stage 4-5
    • Severe liver dysfunction
    • History of severe hypoglycemia
    • Prolonged NPO status expected (>48 hours)
    • Sepsis or critical illness with unpredictable insulin sensitivity
  • For same-day procedures with brief NPO periods (<12 hours), continue the full 15 units without modification 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.